A sizeable proportion of Salmonella and Campylobacter bacteria is still resistant to antibiotics commonly used in humans and animals, as in previous years, says a report released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2019 in 36 European countries (28 Member States (MS) and eight non-MS).
For 2019, two imported cases of Lassa fever were reported in the Netherlands. No further cases of Lassa fever or other viral haemorrhagic fevers caused by arenaviruses were reported in the EU/EEA in 2019.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 3-9 January 2021 and includes updates on COVID-19, yellow fever, and influenza.
This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.